Clinical Trial Update: A Multicentre, Randomised, Double-blind, Placebo-parallel Controlled Phase Ⅲ Clinical Trial Evaluating the Efficacy and Safety of BXOS110 Injection in the Treatment of Acute Ischaemic Stroke Within 3 Hours of Onset. [Phase 3]

View source ↗

Summary

A multicenter, randomized, double-blind Phase 3 trial is evaluating the efficacy and safety of BXOS110 Injection in acute ischemic stroke within 3 hours of onse…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• BXOS110 Injection (BXOS110)

Snippet

Sponsor: Biocells (Beijing) Biotech Co.,Ltd | Conditions: AIS | Phase 3 | Status: RECRUITING